Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Shattuck Labs, Inc.
Takeda
Novartis
Hackensack Meridian Health
St. Jude Children's Research Hospital
Orca Biosystems, Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Gamida Cell ltd
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center